MTOR and cancer: recent studies, investigated the role of miRNAs such as miRNAs −100, miRNAs −99a, and miRNAs −21 on targeting the mammalian target of the rapamycin (mTOR) pathway, a vital pathway for main cellular functions, including cell growth, proliferation, synthesis, and death, which influence on radiosensitivity of cancer cells [68].